Compile Data Set for Download or QSAR
Report error Found 205 Enz. Inhib. hit(s) with all data for entry = 9305
TargetHepatocyte growth factor receptor(Human)
Incyte Holdings

US Patent
LigandPNGBDBM388786(US9944645, 116 | N-[1-(Methoxymethyl)cyclobutyl]-4...)
Affinity DataIC50: 500nMAssay Description:Briefly, histidine-tagged c-Met catalytic domain fusion protein was used for the assay. IC50 measurements were based on the degree of phosphorylation...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/4/2021
Entry Details
US Patent

TargetHepatocyte growth factor receptor(Human)
Incyte Holdings

US Patent
LigandPNGBDBM388787(US9944645, 117 | N-[(1S)-1-(Methoxymethyl)-2-methy...)
Affinity DataIC50: 500nMAssay Description:Briefly, histidine-tagged c-Met catalytic domain fusion protein was used for the assay. IC50 measurements were based on the degree of phosphorylation...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/4/2021
Entry Details
US Patent

TargetHepatocyte growth factor receptor(Human)
Incyte Holdings

US Patent
LigandPNGBDBM388784(US9944645, 114 | N-Cyclopropyl-N-methyl-4-[7-(1-qu...)
Affinity DataIC50: 500nMAssay Description:Briefly, histidine-tagged c-Met catalytic domain fusion protein was used for the assay. IC50 measurements were based on the degree of phosphorylation...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/4/2021
Entry Details
US Patent

TargetHepatocyte growth factor receptor(Human)
Incyte Holdings

US Patent
LigandPNGBDBM388785(US9944645, 115 | N-[1-(Methoxymethyl)cyclopropyl]-...)
Affinity DataIC50: 500nMAssay Description:Briefly, histidine-tagged c-Met catalytic domain fusion protein was used for the assay. IC50 measurements were based on the degree of phosphorylation...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/4/2021
Entry Details
US Patent

TargetHepatocyte growth factor receptor(Human)
Incyte Holdings

US Patent
LigandPNGBDBM388782(US9944645, 112 | (3R)-1-{4-[7-(1-quinolin-6-ylcycl...)
Affinity DataIC50: 500nMAssay Description:Briefly, histidine-tagged c-Met catalytic domain fusion protein was used for the assay. IC50 measurements were based on the degree of phosphorylation...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/4/2021
Entry Details
US Patent

TargetHepatocyte growth factor receptor(Human)
Incyte Holdings

US Patent
LigandPNGBDBM388783(US9944645, 113 | 4-(7-(1-(Quinolin-6-yl)cyclopropy...)
Affinity DataIC50: 500nMAssay Description:Briefly, histidine-tagged c-Met catalytic domain fusion protein was used for the assay. IC50 measurements were based on the degree of phosphorylation...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/4/2021
Entry Details
US Patent

TargetHepatocyte growth factor receptor(Human)
Incyte Holdings

US Patent
LigandPNGBDBM388780(US9944645, 110 | N-(2-Hydroxy-1,1-dimethylethyl)-4...)
Affinity DataIC50: 500nMAssay Description:Briefly, histidine-tagged c-Met catalytic domain fusion protein was used for the assay. IC50 measurements were based on the degree of phosphorylation...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/4/2021
Entry Details
US Patent

TargetHepatocyte growth factor receptor(Human)
Incyte Holdings

US Patent
LigandPNGBDBM388781(US9944645, 111 | N-[(1S)-1-Benzyl-2-hydroxyethyl]-...)
Affinity DataIC50: 500nMAssay Description:Briefly, histidine-tagged c-Met catalytic domain fusion protein was used for the assay. IC50 measurements were based on the degree of phosphorylation...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/4/2021
Entry Details
US Patent

TargetHepatocyte growth factor receptor(Human)
Incyte Holdings

US Patent
LigandPNGBDBM388778(US9944645, 108 | N-Cyclobutyl-4-[7-(1-quinolin-6-y...)
Affinity DataIC50: 500nMAssay Description:Briefly, histidine-tagged c-Met catalytic domain fusion protein was used for the assay. IC50 measurements were based on the degree of phosphorylation...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/4/2021
Entry Details
US Patent

TargetHepatocyte growth factor receptor(Human)
Incyte Holdings

US Patent
LigandPNGBDBM388779(US9944645, 109 | N-(1-Pyridin-2-ylcyclopropyl)-4-[...)
Affinity DataIC50: 500nMAssay Description:Briefly, histidine-tagged c-Met catalytic domain fusion protein was used for the assay. IC50 measurements were based on the degree of phosphorylation...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/4/2021
Entry Details
US Patent

TargetHepatocyte growth factor receptor(Human)
Incyte Holdings

US Patent
LigandPNGBDBM388776(US9944645, 106 | N-(Pyridin-2-ylmethyl)-4-[7-(1-qu...)
Affinity DataIC50: 500nMAssay Description:Briefly, histidine-tagged c-Met catalytic domain fusion protein was used for the assay. IC50 measurements were based on the degree of phosphorylation...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/4/2021
Entry Details
US Patent

TargetHepatocyte growth factor receptor(Human)
Incyte Holdings

US Patent
LigandPNGBDBM388777(US9944645, 107 | N-Cyclopropyl-4-[7-(1-quinolin-6-...)
Affinity DataIC50: 500nMAssay Description:Briefly, histidine-tagged c-Met catalytic domain fusion protein was used for the assay. IC50 measurements were based on the degree of phosphorylation...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/4/2021
Entry Details
US Patent

TargetHepatocyte growth factor receptor(Human)
Incyte Holdings

US Patent
LigandPNGBDBM388774(US9944645, 104 | 2-Fluoro-4-(7-(1-(quinolin-6-yl)c...)
Affinity DataIC50: 500nMAssay Description:Briefly, histidine-tagged c-Met catalytic domain fusion protein was used for the assay. IC50 measurements were based on the degree of phosphorylation...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/4/2021
Entry Details
US Patent

TargetHepatocyte growth factor receptor(Human)
Incyte Holdings

US Patent
LigandPNGBDBM388775(US9944645, 105 | 4-[7-(1-Quinolin-6-ylcyclopropyl)...)
Affinity DataIC50: 500nMAssay Description:Briefly, histidine-tagged c-Met catalytic domain fusion protein was used for the assay. IC50 measurements were based on the degree of phosphorylation...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/4/2021
Entry Details
US Patent

TargetHepatocyte growth factor receptor(Human)
Incyte Holdings

US Patent
LigandPNGBDBM388772(US9944645, 102 | 2-Fluoro-N-methyl-4-[7-(1-quinoli...)
Affinity DataIC50: 500nMAssay Description:Briefly, histidine-tagged c-Met catalytic domain fusion protein was used for the assay. IC50 measurements were based on the degree of phosphorylation...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/4/2021
Entry Details
US Patent

TargetHepatocyte growth factor receptor(Human)
Incyte Holdings

US Patent
LigandPNGBDBM388773(US9944645, 103 | 2-Fluoro-N-[1-(methoxymethyl)cycl...)
Affinity DataIC50: 500nMAssay Description:Briefly, histidine-tagged c-Met catalytic domain fusion protein was used for the assay. IC50 measurements were based on the degree of phosphorylation...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/4/2021
Entry Details
US Patent

TargetHepatocyte growth factor receptor(Human)
Incyte Holdings

US Patent
LigandPNGBDBM388802(US9944645, 132 | N-(1S)-1-[(Dimethylamino)carbonyl...)
Affinity DataIC50: 500nMAssay Description:Briefly, histidine-tagged c-Met catalytic domain fusion protein was used for the assay. IC50 measurements were based on the degree of phosphorylation...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/4/2021
Entry Details
US Patent

TargetHepatocyte growth factor receptor(Human)
Incyte Holdings

US Patent
LigandPNGBDBM388803(US9944645, 133 | N-[(1S)-1-(Azetidin-1-ylcarbonyl)...)
Affinity DataIC50: 500nMAssay Description:Briefly, histidine-tagged c-Met catalytic domain fusion protein was used for the assay. IC50 measurements were based on the degree of phosphorylation...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/4/2021
Entry Details
US Patent

TargetHepatocyte growth factor receptor(Human)
Incyte Holdings

US Patent
LigandPNGBDBM388800(US9944645, 130 | 3-{2-Fluoro-4-[7-(quinolin-6-ylme...)
Affinity DataIC50: 500nMAssay Description:Briefly, histidine-tagged c-Met catalytic domain fusion protein was used for the assay. IC50 measurements were based on the degree of phosphorylation...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/4/2021
Entry Details
US Patent

TargetHepatocyte growth factor receptor(Human)
Incyte Holdings

US Patent
LigandPNGBDBM388801(US9944645, 131 | N-(1S)-2,2-Dimethyl-1-[(methylami...)
Affinity DataIC50: 500nMAssay Description:Briefly, histidine-tagged c-Met catalytic domain fusion protein was used for the assay. IC50 measurements were based on the degree of phosphorylation...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/4/2021
Entry Details
US Patent

TargetHepatocyte growth factor receptor(Human)
Incyte Holdings

US Patent
LigandPNGBDBM388798(US9944645, 128 | 2-Fluoro-N-(trans-4-hydroxycycloh...)
Affinity DataIC50: 500nMAssay Description:Briefly, histidine-tagged c-Met catalytic domain fusion protein was used for the assay. IC50 measurements were based on the degree of phosphorylation...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/4/2021
Entry Details
US Patent

TargetHepatocyte growth factor receptor(Human)
Incyte Holdings

US Patent
LigandPNGBDBM388799(US9944645, 129 | 6-{2-[3-Fluoro-4-(1H-imidazol-1-y...)
Affinity DataIC50: 500nMAssay Description:Briefly, histidine-tagged c-Met catalytic domain fusion protein was used for the assay. IC50 measurements were based on the degree of phosphorylation...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/4/2021
Entry Details
US Patent

TargetHepatocyte growth factor receptor(Human)
Incyte Holdings

US Patent
LigandPNGBDBM388796(US9944645, 126 | (3R)-1-{2-Fluoro-4-[7-(quinolin-6...)
Affinity DataIC50: 500nMAssay Description:Briefly, histidine-tagged c-Met catalytic domain fusion protein was used for the assay. IC50 measurements were based on the degree of phosphorylation...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/4/2021
Entry Details
US Patent

TargetHepatocyte growth factor receptor(Human)
Incyte Holdings

US Patent
LigandPNGBDBM388797(US9944645, 127 | 2-Fluoro-4-[7-(quinolin-6-ylmethy...)
Affinity DataIC50: 500nMAssay Description:Briefly, histidine-tagged c-Met catalytic domain fusion protein was used for the assay. IC50 measurements were based on the degree of phosphorylation...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/4/2021
Entry Details
US Patent

TargetHepatocyte growth factor receptor(Human)
Incyte Holdings

US Patent
LigandPNGBDBM388794(US9944645, 124 | 2-Fluoro-N-[1-(methoxymethyl)cycl...)
Affinity DataIC50: 500nMAssay Description:Briefly, histidine-tagged c-Met catalytic domain fusion protein was used for the assay. IC50 measurements were based on the degree of phosphorylation...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/4/2021
Entry Details
US Patent

TargetHepatocyte growth factor receptor(Human)
Incyte Holdings

US Patent
LigandPNGBDBM388795(US9944645, 125 | 2-Fluoro-4-[7-(quinolin-6-ylmethy...)
Affinity DataIC50: 500nMAssay Description:Briefly, histidine-tagged c-Met catalytic domain fusion protein was used for the assay. IC50 measurements were based on the degree of phosphorylation...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/4/2021
Entry Details
US Patent

TargetHepatocyte growth factor receptor(Human)
Incyte Holdings

US Patent
LigandPNGBDBM388792(US9944645, 122 | N-{(1R)-1-[(Dimethylamino)carbony...)
Affinity DataIC50: 500nMAssay Description:Briefly, histidine-tagged c-Met catalytic domain fusion protein was used for the assay. IC50 measurements were based on the degree of phosphorylation...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/4/2021
Entry Details
US Patent

TargetHepatocyte growth factor receptor(Human)
Incyte Holdings

US Patent
LigandPNGBDBM388793(US9944645, 123 | N-Cyclopropyl-2-fluoro-4-[7-(quin...)
Affinity DataIC50: 500nMAssay Description:Briefly, histidine-tagged c-Met catalytic domain fusion protein was used for the assay. IC50 measurements were based on the degree of phosphorylation...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/4/2021
Entry Details
US Patent

TargetHepatocyte growth factor receptor(Human)
Incyte Holdings

US Patent
LigandPNGBDBM388790(US9944645, 120 | N-Pyrimidin-4-yl-4-[7-(1-quinolin...)
Affinity DataIC50: 500nMAssay Description:Briefly, histidine-tagged c-Met catalytic domain fusion protein was used for the assay. IC50 measurements were based on the degree of phosphorylation...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/4/2021
Entry Details
US Patent

TargetHepatocyte growth factor receptor(Human)
Incyte Holdings

US Patent
LigandPNGBDBM388791(US9944645, 121 | N-[4-(Methoxymethyl)tetrahydro-2H...)
Affinity DataIC50: 500nMAssay Description:Briefly, histidine-tagged c-Met catalytic domain fusion protein was used for the assay. IC50 measurements were based on the degree of phosphorylation...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/4/2021
Entry Details
US Patent

TargetHepatocyte growth factor receptor(Human)
Incyte Holdings

US Patent
LigandPNGBDBM388788(US9944645, 118 | N-[4-(Methoxymethyl)tetrahydro-2H...)
Affinity DataIC50: 500nMAssay Description:Briefly, histidine-tagged c-Met catalytic domain fusion protein was used for the assay. IC50 measurements were based on the degree of phosphorylation...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/4/2021
Entry Details
US Patent

TargetHepatocyte growth factor receptor(Human)
Incyte Holdings

US Patent
LigandPNGBDBM388789(US9944645, 119 | 4-[7-(1-Quinolin-6-ylcyclopropyl)...)
Affinity DataIC50: 500nMAssay Description:Briefly, histidine-tagged c-Met catalytic domain fusion protein was used for the assay. IC50 measurements were based on the degree of phosphorylation...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/4/2021
Entry Details
US Patent

TargetHepatocyte growth factor receptor(Human)
Incyte Holdings

US Patent
LigandPNGBDBM388818(US9944645, 148 | N-[2-(Dimethylamino)ethyl]-2-fluo...)
Affinity DataIC50: 500nMAssay Description:Briefly, histidine-tagged c-Met catalytic domain fusion protein was used for the assay. IC50 measurements were based on the degree of phosphorylation...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/4/2021
Entry Details
US Patent

TargetHepatocyte growth factor receptor(Human)
Incyte Holdings

US Patent
LigandPNGBDBM388819(US9944645, 149 | 2-Fluoro-N-(2-piperidin-1-ylethyl...)
Affinity DataIC50: 500nMAssay Description:Briefly, histidine-tagged c-Met catalytic domain fusion protein was used for the assay. IC50 measurements were based on the degree of phosphorylation...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/4/2021
Entry Details
US Patent

TargetHepatocyte growth factor receptor(Human)
Incyte Holdings

US Patent
LigandPNGBDBM388816(US9944645, 146 | N-(Cyclopropylmethyl)-2-fluoro-4-...)
Affinity DataIC50: 500nMAssay Description:Briefly, histidine-tagged c-Met catalytic domain fusion protein was used for the assay. IC50 measurements were based on the degree of phosphorylation...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/4/2021
Entry Details
US Patent

TargetHepatocyte growth factor receptor(Human)
Incyte Holdings

US Patent
LigandPNGBDBM388817(US9944645, 147 | 2-Fluoro-4-[7-(quinolin-6-ylmethy...)
Affinity DataIC50: 500nMAssay Description:Briefly, histidine-tagged c-Met catalytic domain fusion protein was used for the assay. IC50 measurements were based on the degree of phosphorylation...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/4/2021
Entry Details
US Patent

TargetHepatocyte growth factor receptor(Human)
Incyte Holdings

US Patent
LigandPNGBDBM388814(US9944645, 144 | 2-Fluoro-N-[1-(methoxymethyl)cycl...)
Affinity DataIC50: 500nMAssay Description:Briefly, histidine-tagged c-Met catalytic domain fusion protein was used for the assay. IC50 measurements were based on the degree of phosphorylation...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/4/2021
Entry Details
US Patent

TargetHepatocyte growth factor receptor(Human)
Incyte Holdings

US Patent
LigandPNGBDBM388815(US9944645, 145 | 2-Fluoro-N-[4-(methoxymethyl)tetr...)
Affinity DataIC50: 500nMAssay Description:Briefly, histidine-tagged c-Met catalytic domain fusion protein was used for the assay. IC50 measurements were based on the degree of phosphorylation...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/4/2021
Entry Details
US Patent

TargetHepatocyte growth factor receptor(Human)
Incyte Holdings

US Patent
LigandPNGBDBM388812(US9944645, 142 | 2-Fluoro-N-[(1S,2S)-2-hydroxycycl...)
Affinity DataIC50: 500nMAssay Description:Briefly, histidine-tagged c-Met catalytic domain fusion protein was used for the assay. IC50 measurements were based on the degree of phosphorylation...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/4/2021
Entry Details
US Patent

TargetHepatocyte growth factor receptor(Human)
Incyte Holdings

US Patent
LigandPNGBDBM388813(US9944645, 143 | 2-Fluoro-N-(2-hydroxyethyl)-4-[7-...)
Affinity DataIC50: 500nMAssay Description:Briefly, histidine-tagged c-Met catalytic domain fusion protein was used for the assay. IC50 measurements were based on the degree of phosphorylation...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/4/2021
Entry Details
US Patent

TargetHepatocyte growth factor receptor(Human)
Incyte Holdings

US Patent
LigandPNGBDBM388810(US9944645, 140 | 2-{4-[7-(Quinolin-6-ylmethyl)imid...)
Affinity DataIC50: 500nMAssay Description:Briefly, histidine-tagged c-Met catalytic domain fusion protein was used for the assay. IC50 measurements were based on the degree of phosphorylation...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/4/2021
Entry Details
US Patent

TargetHepatocyte growth factor receptor(Human)
Incyte Holdings

US Patent
LigandPNGBDBM388811(US9944645, 141 | Methyl 4-{4-[7-(quinolin-6-ylmeth...)
Affinity DataIC50: 500nMAssay Description:Briefly, histidine-tagged c-Met catalytic domain fusion protein was used for the assay. IC50 measurements were based on the degree of phosphorylation...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/4/2021
Entry Details
US Patent

TargetHepatocyte growth factor receptor(Human)
Incyte Holdings

US Patent
LigandPNGBDBM388808(US9944645, 138 | 3-{4-[7-(Quinolin-6-ylmethyl)imid...)
Affinity DataIC50: 500nMAssay Description:Briefly, histidine-tagged c-Met catalytic domain fusion protein was used for the assay. IC50 measurements were based on the degree of phosphorylation...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/4/2021
Entry Details
US Patent

TargetHepatocyte growth factor receptor(Human)
Incyte Holdings

US Patent
LigandPNGBDBM388809(US9944645, 139 | 4-[7-(Quinolin-6-ylmethyl)imidazo...)
Affinity DataIC50: 500nMAssay Description:Briefly, histidine-tagged c-Met catalytic domain fusion protein was used for the assay. IC50 measurements were based on the degree of phosphorylation...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/4/2021
Entry Details
US Patent

TargetHepatocyte growth factor receptor(Human)
Incyte Holdings

US Patent
LigandPNGBDBM388806(US9944645, 136 | N-{(1R)-1-[(Dimethylamino)carbony...)
Affinity DataIC50: 500nMAssay Description:Briefly, histidine-tagged c-Met catalytic domain fusion protein was used for the assay. IC50 measurements were based on the degree of phosphorylation...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/4/2021
Entry Details
US Patent

TargetHepatocyte growth factor receptor(Human)
Incyte Holdings

US Patent
LigandPNGBDBM388807(US9944645, 137 | N-[(1R)-1-(Azetidin-1-ylcarbonyl)...)
Affinity DataIC50: 500nMAssay Description:Briefly, histidine-tagged c-Met catalytic domain fusion protein was used for the assay. IC50 measurements were based on the degree of phosphorylation...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/4/2021
Entry Details
US Patent

TargetHepatocyte growth factor receptor(Human)
Incyte Holdings

US Patent
LigandPNGBDBM388804(US9944645, 134 | N-{(1S)-1-[(Dimethylamino)carbony...)
Affinity DataIC50: 500nMAssay Description:Briefly, histidine-tagged c-Met catalytic domain fusion protein was used for the assay. IC50 measurements were based on the degree of phosphorylation...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/4/2021
Entry Details
US Patent

TargetHepatocyte growth factor receptor(Human)
Incyte Holdings

US Patent
LigandPNGBDBM388805(US9944645, 135 | 2-Fluoro-N-{(1R)-3-methyl-1-[(met...)
Affinity DataIC50: 500nMAssay Description:Briefly, histidine-tagged c-Met catalytic domain fusion protein was used for the assay. IC50 measurements were based on the degree of phosphorylation...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/4/2021
Entry Details
US Patent

TargetHepatocyte growth factor receptor(Human)
Incyte Holdings

US Patent
LigandPNGBDBM388834(US9944645, 164 | 6-{1-[6-(3-Fluoro-4-[(3S)-3-fluor...)
Affinity DataIC50: 500nMAssay Description:Briefly, histidine-tagged c-Met catalytic domain fusion protein was used for the assay. IC50 measurements were based on the degree of phosphorylation...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/4/2021
Entry Details
US Patent

TargetHepatocyte growth factor receptor(Human)
Incyte Holdings

US Patent
LigandPNGBDBM388835(US9944645, 165 | 2-Fluoro-N-(pyridin-2-ylmethyl)-4...)
Affinity DataIC50: 500nMAssay Description:Briefly, histidine-tagged c-Met catalytic domain fusion protein was used for the assay. IC50 measurements were based on the degree of phosphorylation...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/4/2021
Entry Details
US Patent

Displayed 1 to 50 (of 205 total ) | Next | Last >>
Jump to: